Brief: Biogen Q4 Adjusted EPS USD 1.99 Vs. IBES Estimate USD 1.59
06/02/2026 11:56
Feb 06 (Reuters) - Biogen Q4 EPS USD -0.33. Q4 revenue USD 2,300 million vs. IBES estimate USD 2,204 million outlook FY adjusted EPS USD 15.28
Recent news on Biogen
See all newsHealth Rounds: Old cancer drug may help restore fertility for certain women
U.S. STOCKS ON THE MOVE-FactSet, Moderna, Goldman Sachs
U.S. STOCKS ON THE MOVE-Biogen, Incyte, Quantum Cyber
Biogen rises; co scales back drug programs acquired through $5.6 bln Apellis deal
Biogen scales back Apellis programs, trims research roles after $5.6 billion buyout